Expansion and Activation of Human Natural Killer Cells ex vivo in the Presence of Transgenic Feeder Cells

Preliminary results of clinical trials show that the use of activated and expanded ex vivo natural killer cells is a promising tool for adoptive immunotherapy of acute myeloid leukemia, as well as a number of solid tumors, when used together with targeted monoclonal antibodies. However, the introduc...

Ausführliche Beschreibung